Rational design of multifunctional polymer therapeutics for cancer theranostics

Keyphrases

• Rational Design 100%
• Polymer Therapeutics 100%
• Cancer Theranostics 100%
• Multifunctional Polymer 100%
• Tumor 50%
• Antiangiogenic 50%
• Antiangiogenic Agents 50%
• Molecular Mechanism 25%
• Fast-growing 25%
• Delayed Onset 25%
• Dormant 25%
• Microenvironment 25%
• Cancer Treatment 25%
• Monotherapy 25%
• Integrin 25%
• Tumor Progression 25%
• Tumor Cells 25%
• Antitumor 25%
• Osteosarcoma 25%
• Multimodality 25%
• Primary Tumor 25%
• Therapeutic Potential 25%
• Paclitaxel 25%
• Molecular Imaging Techniques 25%
• Advanced Malignancies 25%
• Targeting Moieties 25%
• Bisphosphonates 25%
• Tumor Dormancy 25%
• Tumor Endothelial Cells 25%
• Novel Polymers 25%
• Angiogenesis-dependent Diseases 25%
• Bone Metastasis 25%
• Improved Efficacy 25%
• Metastatic Tumor 25%
• RGD Peptide 25%
• Bispecific 25%
• Growing Tumor 25%
• Tumor Mouse Model 25%
• TNP-470 25%
• Novel Architectures 25%
• Tumor Response 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Malignant Neoplasm 100%
• Neoplasm 100%
• Angiogenesis Inhibitor 60%
• Disease 40%
• Monotherapy 20%
• Mouse Model 20%
• Tumor Growth 20%
• Antiinfective Agent 20%
• Clinical Study 20%
• Osteosarcoma 20%
• Metastasis 20%
• Primary Tumor 20%
• Paclitaxel 20%
• Bisphosphonic Acid Derivative 20%
• Integrin 20%
• Epithelium Tumor 20%
• Peptidomimetic Agent 20%
• Antiangiogenic 20%
• Bone Metastasis 20%
• Preclinical Study 20%
• Picric Acid 20%